"Smruthi Organics Limited (590046) – Financial and Strategic SWOT Analysis Review" Published – PR Inside

It operates in the bulk drugs and drug intermediates segment. Its products include diloxanide furcate, norfloxacin, zidovudine, ciprofloxacin, pefloxacin, metformin hcl, amlodipine, chlorhexidine base, carbidopa, enrofloxacin and phthaloyl amlodipine.